Contrasting compositions of sitting, standing, stepping, and sleeping time: associations with glycaemic outcome by diabetes risk by Brakenridge, Christian J. et al.
Contrasting compositions of sitting, standing, stepping, and sleeping time:
associations with glycaemic outcome by diabetes risk
Brakenridge, Christian J.; Healy, Genevieve N.; Sethi, Parneet; Carver, Alison; Bellettiere,
John; Salim, Agus; Chastin, Sebastien F.M.; Owen, Neville; Dunstan, David W.
Published in:






Publisher's PDF, also known as Version of record
Link to publication in ResearchOnline
Citation for published version (Harvard):
Brakenridge, CJ, Healy, GN, Sethi, P, Carver, A, Bellettiere, J, Salim, A, Chastin, SFM, Owen, N & Dunstan, DW
2021, 'Contrasting compositions of sitting, standing, stepping, and sleeping time: associations with glycaemic
outcome by diabetes risk', International Journal of Behavioral Nutrition and Physical Activity, vol. 18, 155.
https://doi.org/10.1186/s12966-021-01209-5
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
Take down policy
If you believe that this document breaches copyright please view our takedown policy at https://edshare.gcu.ac.uk/id/eprint/5179 for details
of how to contact us.
Download date: 02. Jan. 2022
Brakenridge et al. Int J Behav Nutr Phys Act          (2021) 18:155  
https://doi.org/10.1186/s12966-021-01209-5
RESEARCH
Contrasting compositions of sitting, 
standing, stepping, and sleeping time: 
associations with glycaemic outcome 
by diabetes risk
Christian J. Brakenridge1,2* , Genevieve N. Healy3 , Parneet Sethi1 , Alison Carver2 , John Bellettiere4 , 
Agus Salim1,5 , Sebastien F. M. Chastin6,7 , Neville Owen1,8  and David W. Dunstan1,2  
Abstract 
Background: Recent evidence suggests that prolonged sitting and its adverse impact on glycaemic indicators 
appear to be proportional to the degree of insulin resistance. To investigate this finding in a free-living context, we 
aimed to examine associations of device-measured 24-h time-use compositions of sitting, standing, stepping, and 
sleeping with fasting glucose (FPG) and 2 h post-load glucose (2hPLG) levels, and to examine separately the associa-
tions with time-use compositions among those at lower and at higher risk of developing type 2 diabetes.
Methods: Cross-sectional analyses examined thigh-worn inclinometer data (activPAL, 7 day, 24 h/day protocol) from 
648 participants (aged 36-80 years) at either lower (< 39 mmol/mol; < 5.7% HbA1c) or higher (≥39 mmol/mol; ≥5.7% 
HbA1c) diabetes risk from the 2011-2012 Australian Diabetes, Obesity and Lifestyle study. Multiple linear regression 
models were used to examine associations of differing compositions with FPG and 2hPLG, with time spent in each 
behaviour allowed to vary up to 60 min.
Results: In general, the associations with the FPG within the time-use compositions were small, with statistically sig-
nificant associations observed for sitting and sleeping (in the lower diabetes risk group) and standing (in higher diabe-
tes risk group) only. For 2hPLG, statistically significant associations were observed for stepping only, with findings simi-
lar between lower (β = − 0.12 95%CI:−0.22, − 0.02) and higher (β = − 0.13 95%CI:−0.26, − 0.01) risk groups. Varying 
the composition had minimal impact on FPG; however 1 h less sitting time and equivalent increase in standing time 
was associated with attenuated FPG levels in higher risk only (Δ FPG% = − 1.5 95%CI: − 2.4, − 0.5). Large differences in 
2hPLG were observed for both groups when varying the composition. One hour less sitting with equivalent increase 
in stepping was associated with attenuated 2hPLG, with estimations similar in lower (Δ 2hPLG% = − 3.8 95%CI: − 7.3, 
− 0.2) and higher (Δ 2hPLG% = − 5.0 95%CI: − 9.7, − 0.0) risk for diabetes.
Conclusions: In middle-aged and older adults, glycaemic control could be improved by reducing daily sitting 
time and replacing it with stepping. Standing could also be beneficial for those at higher risk of developing type 2 
diabetes.
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Background
Clinical practice guidelines for the prevention of type 
2 diabetes emphasise lifestyle management as the first 
priority for those identified with elevated risk [1]. A pri-
mary focus has been on promoting regular participation 
in moderate-to-vigorous intensity physical activity. More 
recently, addressing sedentary (sitting) time has been 
included in guidelines [2] based on emerging observa-
tional and acute experimental evidence regarding the 
detrimental relationships of high volumes of time spent 
sitting with risk for type 2 diabetes [3] and its precursors 
[4], and the potential benefits of replacing sitting time 
with physical activity and/or standing [5–7].
Consideration of 24 h time-use as a composition of dis-
tinct yet competing activities (sitting, standing, stepping, 
and sleep) is increasingly being adopted in observational 
research to examine associations with health outcomes 
and risk biomarkers [8–10]. This has been made pos-
sible by the use of continuously-worn activity-monitor 
devices that collect time- and date-stamped information, 
enabling the 24 h period to be categorised entirely into 
the sum of time spent in different behaviours. This has 
led to the creation of integrated movement guidelines, 
that have made recommendations on how to best utilise 
the 24 h for greatest health benefit [11]. There have been 
numerous studies that have suggested that time spent 
sitting [7], standing [12], in physical activities [13], and 
in sleep [14] can have distinct associations with glucose 
outcomes. However, the majority of these studies did not 
differentiate by posture (instead, they did so using device 
acceleration thresholds). Nor have they considered these 
behaviours as interrelated exposures [15], where spend-
ing time in one behaviour will necessarily mean less time 
undertaken in the remaining behaviours within the same 
24 h period.
Findings from recent laboratory-based trials suggest 
that the detrimental impacts of prolonged sitting time 
on blood glucose may be proportional to the degree of 
underlying insulin resistance [16], but it is not known if 
this is manifested in the free-living context. Furthermore, 
it is unclear if changing sitting, standing, and activity 
levels have differential impact depending on underly-
ing risk for developing type 2 diabetes. This has impor-
tant implications for the tailoring of public health advice, 
and for clinical practice guidelines targeting vulnerable 
populations.
To address these evidence gaps, compositional data 
analyses (CoDA) were used to examine the associations 
with fasting plasma glucose (FPG) and 2 h post-load glu-
cose (2hPLG) of device-measured components of 24 h 
time-use (sitting, standing, stepping, and sleeping) in the 
free-living context in middle-aged and older Australian 
adults. Compositions with varying time spent between 
components were compared between those at lower and 
higher risk for type 2 diabetes.
Methods
Participants and setting
The Australian Diabetes, Obesity and Lifestyle Study 
(AusDiab) baseline study methods and response rates are 
described in detail elsewhere [17]. In brief, the baseline 
study was a national population-based survey of 11,247 
adults aged ≥25 years in 1999-2000. A stratified cluster 
sampling approach was undertaken, with strata selected 
based upon the six states and the Northern Territory of 
Australia. Subsequent follow-ups occurred in 2004–2005 
(n = 6400) and 2011-2012 (n = 4614). At the 2011/2012 
follow-up, a sub-sample of participants were invited to 
wear an activity monitor as described elsewhere [7]. Eli-
gible participants (ambulatory, and not pregnant) were 
recruited daily in a consecutive manner until either a 
quota was reached (n = 5) or no more monitors were 
available. Of the 1014 approached, 782 consented to 
wearing the monitor, and 741 wore the monitor for at 
least one valid day. For these analyses, the following 
exclusions were applied: those with less than four valid 
monitor-wear days (n = 21), those with known diabetes 
(diagnosed by physician and taking hypoglycaemic medi-
cation or insulin) at the assessment (n = 37); those preg-
nant (n = 2); and those with missing covariates (n = 33). 
A small number of participants missed assessment of 
2hPLG (n = 8) and FPG (n = 1) in the oral glucose toler-
ance test (OGTT) assessment. Thus, the final cross-sec-
tional study was conducted with 647 for the FPG analysis 
and 640 for the 2hPLG analysis. The sample was strati-
fied into two groups according to their HbA1c (glycated 
hemoglobin) levels: lower risk for diabetes (< 39 mmol/
mol, < 5.7% HbA1c), and higher risk (≥39 mmol/mol, 
≥5.7 HbA1c). This was conducted a priori and based on 
experimental research suggesting that behaviours are 
associated with varied glucose outcomes depending on 
the degree of dysmetabolism [16]. Stratification is also 
in accordance with the American Diabetes Association’s 
diagnosis classification for prediabetes [18].
Data collection
On the day of recruitment, participants followed stand-
ard protocols as per the main AusDiab study proce-
dures [19]. Following an overnight fast (minimum 8 h), 
participants underwent biochemical and anthropo-
metric assessments and completed a series of question-
naires at their local testing site. FPG and HbA1c were 
taken initially, followed by a standard 2 h 75-g OGTT 
[20]. The activity monitor was put on either on the day 
of the assessment or the following day. Questionnaires 
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(self-completed and interviewer administered) were used 
to collect data on confounding variables.
Device‑measured sitting, standing, stepping, and sleep 
time
The time-use composition was derived from measure-
ments using the activPAL3 activity monitor (PAL tech-
nologies Limited, Glasgow, UK; version 6.4.1); this device 
has been shown to be accurate and reliable for use with 
adults and older adults [21]. Each monitor was initialised 
with the default settings (20 Hz) and waterproofed by 
covering it in a nitrile sleeve and then encased in trans-
parent Hypafix. It was then secured anteriorly to the 
participant’s right thigh at the approximate midline. Par-
ticipants were instructed to wear the monitor continu-
ously for seven consecutive days (24 h/day, keeping the 
device attached for showering/bathing), and to record 
in a standardised diary their sleep and monitor removal 
time (if it did occur). The device was mailed back to the 
AusDiab research staff in a reply-paid envelope at com-
pletion. Monitor data were processed using SAS 9.3 
(SAS institute Inc., Cary, NC, USA). An invalid wear day 
was considered to be when monitor wear time was less 
than 80% of waking hours, or less than 10 h if the par-
ticipant’s diary was missing sleep and wake times. Inva-
lid wear days were excluded from data analysis. If sleep 
and wake times were not reported in the diary they were 
estimated using an automated algorithmic method [22], 
which demonstrated almost perfect agreement for most 
participants (median kappa 0.94 in 88% of participants). 
Sleep time was deduced by subtracting all waking behav-
iour and unworn monitor time from 24 h. Across all valid 
days, the average time spent in sitting, standing, stepping, 
and sleeping within a 24 h period was calculated.
Glycaemic measures
Blood samples were collected via venipuncture with 
whole blood collected into fluoride-oxalate contain-
ing tubes for the analysis of plasma glucose, and EDTA 
containing tubes for the analysis of HbA1c. All blood 
specimens were centrifuged on-site in order to separate 
plasma, which was then immediately aliquoted for test-
ing and storage. Storage entailed either the immediate 
transport of the sample to a central independent labo-
ratory (Healthscope Pathology) or to the site freezer 
where it was kept at − 20 °C and subsequently at − 80 °C 
within 1 to 2 weeks after collection. HbA1c was meas-
ured with liquid chromatography method (Bio-Rad Vari-
ance Hemoglobin Testing System; Bio-Rad, Hercules Ca, 
USA). FPG and 2hPLG were measured by the hexoki-
nase method using a Siemens Advia 2400 (Siemens AG, 
Munich, Germany).
Other measures
Backwards elimination was performed on a set of con-
founders previously identified in the activity monitor 
subsample (covariate elimination where p > 0.2) [7]. 
Variables excluded were contraceptive medication, 
ethnicity, employment status (blue collar, white collar, 
unemployed), occupation type (manager, professional, 
technician, service worker, clerical worker, sales worker, 
machinery, labourer worker, labourer, never worked), 
fibre intake, and marital status. Smoking status and 
menopausal status were excluded, however given their 
potential for modifying glucose metabolism; they were 
added back into the confounder adjusted models. Con-
founders used for all models included: age, menopausal 
status (self-reported pre, peri, post-menopausal sta-
tus, or male), education attainment, income category, 
smoking category, depression status [23], diet quality 
[24], energy intake, alcohol and calcium intake. These 
analyses did not account for confounding by adiposity 
as it was considered on the causal pathway and thus a 
mediator of the relationships. A separate analysis with 
adjustment by waist circumference revealed similar 
magnitude and direction for all relationships.
Statistical analyses
Analyses were conducted using Stata 14.2 (StataCorp 
LP, College Station, TX, USA) and R version 3.6.1. 
Group characteristics were compared using analysis 
of variance for continuous variables, and by chi-square 
tests for categorical variables. In the linear regres-
sions, glucose outcomes were log transformed which 
improved normality of residuals. Multicollinearity 
among confounders were assessed using variance infla-
tion factor (VIF) methods, all models had VIF values 
below 2.5.
The CoDA method procedure has been described in 
detail previously [9, 25]. The 24 h day (1440 min) exam-
ined was finitely comprised of sitting, standing, stepping, 
and sleeping time-use components. Daily totals of all 
activities were calculated into geometric means per dia-
betes risk group using Aitchison’s perturbation method 
(“acomp” function in R package: Compositions). Means 
were transformed into isometric log ratios and compared 
between higher and lower risk groups. In order to explain 
significant group difference, geometric means were first 
computed as a log ratio (higher/lower risk), and then 
bootstrapped (as described by Gupta et al. [26]) to calcu-
late the percentage difference (difference between two log 
ratios) between the two geometric means with upper and 
lower limits of 95% confidence intervals. Overall group 
difference was determined with Hotelling’s test (R pack-
age: “Hotelling”).
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The compositional modeling employs isometric log 
ratios (ilr) of the behaviour components. In brief, the 
outcome (log glucose) is dependent on the sum of com-
position isometric log ratios and covariates through a 
regression model.
Where ilr1, ilr2 and ilr3 are the coordinates of the ilr-
transformed composition. The coefficient β1 is the main 
interest here as it reflects the effect of time spent in one 
behavior relative to the other three. For example, to 
assess the effect of time spent sitting relative to stepping, 
standing, and sleeping, we would use ‘sitting’ as the ref-
erence behavior when performing the ilr transformation 
and compute ilr1 as:
To assess the interaction with diabetes risk, an inter-
action between ilr-transformed variables (ilr1, ilr2, ilr3) 
and diabetes risk group was added to the model and the 
interaction coefficient with ilr1 was examined for statis-
tical significance. To test an outcome’s association with 
relative time spent in the other behaviours, the ilr-trans-
formed variable was recalculated using that behaviour as 
reference and the above procedures were repeated. For 
all behaviours, associations were tested in unadjusted 
and confounder-adjusted models. The models were then 
used to estimate the expected log FPG and 2hPLG values 
with set compositions.
New compositions were made by adding and subtract-
ing 15, 30, 45, and 60 min from the geometric mean val-
ues. The difference (delta) between the estimated log 
glucose value of the new composition and the estimated 
value of the geometric mean composition was calculated 
using R package “deltacomp” [10, 27]. Confidence inter-
vals were determined using the standard error of the delta 
estimate. The estimated differences were then back-trans-
formed and presented as percentage difference from the 
original glucose value. For each of the behaviours, there 
was no requirement to adjust them from zero time as 
every participant participated in at least 1 min in each of 
the behaviours. All hypothesis testing was two-tailed and 
the type I error for all statistical analyses were set at 5%.
Results
Characteristics of participants
Table 1 describes the characteristics of participants with 
lower and higher diabetes risk. Compared to the lower 
risk, the higher risk participants were more likely to be 
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less. There were no significant differences in behav-
iours between the lower risk and higher risk for smok-
ing, energy intake, or dietary quality. Alcohol intake was 
greater in the lower risk (15.5 g) compared to the higher 
risk (11.5 g).
Geometric means for the 24 h day
Table  2 shows the geometric means of sitting, stand-
ing, stepping, and sleeping for the lower and higher risk 
participants. For both the lower and higher risk, sitting 
occupied the largest proportion of the day and stepping 
the smallest. When considering group geometric means 
and variance intervals comparing the two risk groups, 
all percentage differences intersected zero; therefore, 
there were no statistically-significant differences between 
groups. The comparisons using Hotelling’s test confirmed 
no statistically significant difference between the overall 
compositions with p-value > 0.05.
Compositional linear regression modelling
The associations of log glucose outcomes with time spent 
in each behaviour (and consequently less time in remain-
ing behaviours) are presented for both the lower and 
higher diabetes risk participants unadjusted and con-
founder adjusted in Table 3. In the confounder adjusted 
model, for lower risk all associations with FPG were 
weak, with statistically significant associations observed 
for sitting (β = 0.04 95%CI: 0.00, 0.08) and sleeping 
(β = − 0.06 95%CI: − 0.12, − 0.00) only. Associations with 
FPG were also weak in the higher risk, with the only sta-
tistically significant association being with standing time 
(β = − 0.07 95%CI: − 0.12, − 0.01). However, the direc-
tion of the relationships of standing and sleeping with 
FPG were opposite between groups (p < 0.01 for interac-
tion); this was the only statistically significant interac-
tion by diabetes group observed. For 2hPLG, statistically 
significant associations were observed for stepping only, 
with associations similar for the lower (β = − 0.12 95%CI: 
− 0.22, − 0.02) and higher (β = − 0.13 95%CI: − 0.26, 
− 0.01) risk groups. Notably, there was a positive associa-
tion with 2hPLG and sleeping time in the high risk group 
(β = 0.17 95%CI: − 0.04, 0.39); however, this finding did 
not reach statistical significance.
Comparison of compositions with varying time spent 
between behaviours
New compositions were made by adding and subtract-
ing time from geometric mean values. The new compo-
sitions’ estimated glucose values were then compared 
to original mean values in lower and higher risk. Fig-
ure 1 illustrates varying totals of sitting, standing, and 
stepping, and Table 4 shows 60 min composition varia-
tions between two select behaviours.
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Small differences in estimated fasting glucose out-
comes were found when varying the compositions from 
geometric means. In lower risk, increasing sleeping by 
60 min and decreasing sitting by 60 min (Sit→ Sleep) was 
associated with decreased FPG: –1.1%Δ FPG (95%CI: 
− 2.0, − 0.2). Lower sitting time, and higher standing 
time were associated with lower FPG in higher risk only. 
In higher risk, 60 min more standing, and equivalent less 
time sitting (Sit→ Stand) was associated with reduced 
FPG: −1.5%Δ FPG (95%CI: − 2.4, − 0.5). This suggests 
that standing may be more advantageous for the higher 
risk group (Fig. 1A). Increased standing time by 60 min, 
and 60 min less sleeping time (Sleep→ Stand) was asso-
ciated with greater FPG in the lower risk group (1.1%Δ 
FPG (95%CI: 0.0, 2.2)) and reduced FPG in the higher 
risk group (− 1.8%Δ FPG (95%CI: − 3.5, − 0.2)).
The estimated differences in 2hPLG when varying the 
compositions were greater than in FPG. For example, 
Table 1 Sample characteristics stratified by lower and higher risk for diabetes
Table displays mean (standard deviation), or sample n (%)
*Indicates significant difference between stratified groups with p < 0.05
a Known depressive symptoms indicated when CESD score ≥ 10
b Smoking status: Current smoker: smokes now, and ≥ 100 cigarettes in lifetime, Ex-smoker: does not currently smoke and ≥ 100 cigarettes in lifetime, Non-smoker: 
smoked < 100 cigarettes in lifetime and does not currently smoke
Diabetes Risk
Lower Risk (n = 376) Higher Risk (n = 272)
HbA1c, mmol/mol 95% CI 36 (36–37) 41 (41–41)*
HbA1c%, 95 CI 5.4 (5.4–5.5) 5.9 (5.9–5.9)*
FPG, mmol/L (sd) 5.2 (0.5) 5.5 (0.9)*
2hPLG, mmol/L (sd) 5.2 (1.3) 6.0 (2.3)*
Socio-demographic
 Age, years (sd) 56.0 (9.8) 60.2 (9.3)*
 Women, n (%) 198 (52.7%) 165 (60.7%)
 Education, n (%)
  High school or less 93 (24.7%) 95 (34.9%)*
  Technical / Vocational 184 (48.9%) 116 (42.6%)*
  Bachelor degree or higher 99 (26.3%) 61 (22.4%)*
 Income, n (%)
  No income, or not reported 22 (5.9%) 17 (6.2%)
  $1-39,999 per year 65 (17.3%) 66 (24.3%)
  $40,000-79,999 per year 91 (24.2%) 71 (26.1%)
   ≥ $80,000 per year 198 (52.7%) 118 (43.4%)
 Menopause, n (%) women
  Post-menopausal 88 (44.4%) 117 (70.9%)*
  Peri-menopausal 37 (18.7%) 20 (12.1%)*
  Pre-menopausal 73 (36.9%) 28 (17.0%)*
 Known depressive symptoms, n (%)a
  Yes 23 (6.1%) 29 (10.7%)
Behaviour
 Smoking status, n (%)b
  Current smoker 28 (7.4%) 18 (6.6%)
  Ex-smoker 139 (37.0%) 97 (35.7%)
  Non-smoker 209 (55.6%) 157 (57.7%)
 Dietary Intake
  Energy, mcal/day 1.7 (0.65) 1.7 (0.67)
  Dietary quality score 65.7 (12.4) 67.2 (12.6)
  Alcohol, g/day 15.5 (19.1) 11.5 (15.3)*
  Calcium, g/day 0.9 (0.3) 0.9 (0.3)
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less stepping, and more sitting time was associated with 
large differences in 2hPLG from mean values (Fig. 1D) 
in both risk groups. The greatest estimated glucose 
differences were observed when increasing sleep by 
60 min, and decreasing stepping by 60 min which were 
associated with similar values in lower risk (7.8%Δ 
2hPLG (95%CI: 0.9, 15.1)) and higher risk (10.8%Δ 
2hPLG (95%CI: 2.4, 19.9)). While the estimates suggest 
that the higher risk group had more pronounced differ-
ences from the mean, the overlapping confidence inter-
vals equated to no significant difference between risk 
groups with estimations of Δ 2hPLG.
Discussion
This is one of few studies to use a postural-based 
approach to identify sitting, standing, stepping and 
sleeping time with compositional data analysis meth-
ods [28, 29]. We showed that in this sample of middle-
aged and older Australian adults, behaviours composing 
24 h time-use were associated with biomarkers of glu-
cose control, with some potential differences for those 
at lower risk and higher risk for diabetes. Compositions 
that had greater sitting, and lesser equivalent stepping 
time were most detrimental, however this association 
did not differ significantly by diabetes risk group. Com-
positions with greater sitting, and lesser equivalent time 
standing had small but statistically significant detrimen-
tal associations for those with higher risk for diabetes 
only. These findings may have important practical impli-
cations. For example, a person at higher risk of diabetes 
may improve glycaemic control not only with physical 
activity, but with greater levels of standing time (albeit 
more modestly so), which can be achieved over the 
course of the 24 h day.
Interestingly, compositional modeling showed the 
increase to 2hPLG levels with 60 min more sitting (lower 
risk: + 6.9% 95CI%: 0.6, 13.5; higher risk: + 9.1% 95CI%: 
0.6, 18.5) outweighed the attenuation of 2hPLG with 
Table 2 Geometric means of behaviours in those with lower and higher risk for diabetes
a Geometric means expressed as minutes conducted within a 1440 min composition (percentage rounded to complete number)
b Percentage difference refers to the log ratio difference between each behaviour per group converted into percentage. Positive estimated difference indicates 
that the higher risk has a greater level of the given component; negative estimated difference indicates the lower risk has a greater level of the given component. 
Percentage difference and 95% confidence intervals were determined with bootstrapping. Behaviours with confidence intervals that intersect zero should be 
considered to not differ by diabetes risk group
Diabetes Risk Lower Risk (n = 376) Higher Risk (n = 272) Percentage Difference (95% CI)b
Geometric means, mins/1440a
 Sitting 526.4 (36.6%) 530.7 (36.9%) 0.49% (−4.44, 5.41)
 Standing 287.1 (19.9%) 288.5 (20.0%) − 3.90% (−9.36, 1.59)
 Stepping 120.6 (8.4%) 116.0 (8.1%) −0.21% (− 2.20, 1.84)
 Sleeping 505.8 (35.1%) 504.8 (35.1%) 0.80% (−2.56, 4.08)
Table 3 Associations of behaviours with glucose biomarkers overall and in lower and higher risk for diabetes
Beta coefficients presented with 95% confidence interval (CI). Coefficient corresponds to association of time spent in the behaviour with log glucose outcome
All confounder adjusted models adjusted for age, menopausal status (pre, peri, post-menopausal, male), education attainment, income category, smoking category, 
depression, diet quality, energy intake, alcohol, and calcium intake
a p-value interaction indicates where association is statistically different by diabetes risk
*Indicates a statistically significant association, and statistically significant interaction by diabetes risk using p < 0.05 in two tailed analyses















 Sitting 0.05* (0.01, 0.08) 0.06* (0.02, 0.10) 0.03 (- 0.04, 0.10) 0.444 0.02 (- 0.07, 0.12) 0.04 (- 0.07, 0.15) 0.00 (- 0.16, 0.16) 0.647
 Standing -0.05* (- 0.08, -0.02) -0.01 (- 0.05, 0.02) -0.10* (- 0.15, -0.04) 0.012* -0.05 (- 0.14, 0.04) -0.07 (- 0.18, 0.04) -0.05 (- 0.19, 0.09) 0.815
 Stepping -0.02 (- 0.04, 0.01) 0.02 (- 0.02, 0.05) -0.03 (- 0.08, 0.02) 0.133 -0.14* (- 0.22, - 0.07) -0.07 (- 0.16, 0.03) -0.18* (- 0.30, - 0.06) 0.138
 Sleeping 0.02 (- 0.03, 0.07) -0.06* (- 0.12, - 0.00) 0.09* (0.01, 0.18) 0.002* 0.17* (0.04, 0.30) 0.10 (- 0.06, 0.26) 0.24* (0.03, 0.45) 0.298
Confounder adjusted model
 Sitting 0.04* (0.01, 0.08) 0.04* (0.00, 0.08) 0.03 (-0.03, 0.10) 0.479 0.02 (-0.08, 0.11) 0.00 (-0.12, 0.11) 0.01 (- 0.15, 0.18) 0.791
 Standing -0.03 (- 0.06, 0.01) 0.02 (- 0.01, 0.06) -0.07* (- 0.12, - 0.01) 0.002* -0.03 (- 0.11, 0.06) 0.01 (- 0.10, 0.13) -0.05 (- 0.20, 0.09) 0.972
 Stepping -0.02 (- 0.05, 0.01) -0.01 (- 0.04, 0.03) -0.03 (- 0.08, 0.02) 0.396 -0.12* (- 0.20, - 0.05) -0.12* (- 0.22, - 0.02) -0.13* (- 0.26, - 0.01) 0.255
 Sleeping 0.00 (- 0.05, 0.05) -0.06* (- 0.12, - 0.00) 0.07 (- 0.02, 0.15) 0.002* 0.13* (0.00, 0.26) 0.11 (- 0.06, 0.27) 0.17 (- 0.04, 0.39) 0.378
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Fig. 1 Comparing compositions with varying totals of sitting, standing, and stepping and their associated glucose outcomes in lower and higher 
risk for diabetes. Graphs A and B denote compositions with varying time spent sitting (more sitting time and less standing indicated to the left 
of the x-axis) and standing (more standing time and less sitting indicated to the right of the x-axis) and estimation of fasting, and 2 h plasma 
glucose dependent on composition. Graphs C and D denote compositions with varying time spent sitting and stepping. Graphs E and F denote 
compositions with varying time spent standing and stepping. The associated glucose outcomes at a given composition are compared to the 
glucose outcomes at the geometric mean. Difference in glucose between new composition and original are denoted by Δ FPG% and Δ 2hPLG%
Table 4 Varying composition by 1 h and using linear regression models to estimate glucose
Values expressed as the percentage difference (95% CI) between the new composition’s estimated glucose value and the original geometric mean glucose value (Δ 
FPG% or Δ 2hPLG%) for each diabetes risk group
a Compositions tested varied by 60 min from geometric means, for example, “Sit→ Stand” denotes 60 minutes subtracted from sitting time and added to standing 
time geometric means
Varying compositions by 
60  mina
Δ FPG% Δ 2hPLG%
Lower Risk (n = 375) Higher Risk (n = 272) Lower Risk (n = 373) Higher Risk (n = 267)
Sit → Sleep −1.1% (− 2.0, − 0.2) 0.3% (− 1.2, 1.8) 0.9% (− 1.8, 3.6) 1.5% (− 2.1, 5.1)
Sit → Stand 0.0% (−0.8, 0.7) −1.5% (− 2.4, − 0.5) 0.1% (− 1.9, 2.2) −1.0% (− 3.3, 1.3)
Sit → Step −0.6% (− 1.9, 0.7) −1.4% (− 3.4, 0.7) −3.8% (− 7.3, − 0.2) −5.0% (− 9.7, − 0.0)
Stand → Sleep −1.1% (− 2.2, 0.0) 2.1% (0.3, 3.9) 0.7% (− 2.6, 4.1) 2.7% (− 1.7, 7.3)
Stand → Sit −0.1% (− 0.9, 0.7) 1.7% (0.6, 2.9) −0.2% (− 2.6, 2.2) 1.2% (− 1.5, 4.0)
Stand → Step − 0.7% (− 2.4, 1.1) 0.4% (− 2.2, 3.1) −4.0% (− 8.8, 1.1) −3.8% (− 9.8, 2.6)
Step → Sleep −0.3% (− 2.6, 1.9) 2.5% (− 0.8, 5.9) 7.8% (0.9, 15.1) 10.8% (2.4, 19.9)
Step→ Sit 0.7% (− 1.4, 2.8) 2.1% (− 1.2, 5.6) 6.9% (0.6, 13.5) 9.1% (0.6, 18.5)
Step → Stand 0.7% (− 1.8, 3.2) 0.7% (−3.1, 4.5) 7.0% (−0.4, 15.0) 8.1% (− 1.4, 18.5)
Sleep → Sit 1.1% (0.2, 2.1) −0.4% (− 1.9, 1.1) −1.0% (− 3.6, 1.8) −1.7% (− 5.2, 2.0)
Sleep → Stand 1.1% (0.0, 2.2) −1.8% (− 3.5, − 0.2) − 0.8% (− 3.8, 2.3) −2.6% (− 6.6, 1.4)
Sleep → Step 0.5% (− 1.0, 2.1) −1.7% (− 3.7, 0.3) − 4.8% (− 8.8, − 0.6) −6.5% (− 11.0, − 1.8)
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60 min more stepping (lower risk: −3.8% 95CI%: − 7.3, 
− 0.2; higher risk: −5.0% 95CI%: − 9.7, − 0.0), indicating 
a potential ceiling effect of benefit from daily stepping. 
Similar asymmetric relationships have been observed in 
compositional analyses before [9, 10, 29, 30], and previ-
ously hypothesised to be either relevant to the outcomes 
and behaviours observed, or to be inherent to the com-
positional data. For the present findings, it may suggest 
that higher daily sitting deconditions glycaemic control 
at greater levels than what is achieved by stepping to 
improve it. The relationship of time-use and glycaemic 
control should be investigated further to confirm these 
findings.
Standing was inversely associated with FPG in the 
higher risk group only. Whilst there is evidence of 
standing being beneficially associated with mortal-
ity [31–33], many investigations purport that most, if 
not all glucose change is induced by reallocating time 
to movement [6, 29, 34], potentially as standing pro-
duces only marginal increments in muscle activity and 
energy expenditure [28]. The reason why the findings 
are exclusive to the higher risk group is unclear. How-
ever, previously standing has been demonstrated to 
reduce glucose levels in an overweight and obese cohort 
[12], and chronic muscular inactivity is more likely to 
induce hepatic insulin resistance in those with familial 
predisposition for type 2 diabetes [35], indicating that 
the finding may be inherent to the group studied. Future 
studies should investigate the extent to which standing, 
without ambulation is associated with beneficial meta-
bolic outcomes, and clarify whether there is greater 
benefit to those more vulnerable to chronic diseases 
such as people with metabolic impairment or at higher 
risk of type 2 diabetes.
Recent experimental findings have reported that 
the most exaggerated postprandial glucose responses 
to prolonged sitting are evident in those with poorer 
underlying glycaemia, and insulin resistance [16]. 
When skeletal muscles are inactive, GLUT4 expression 
is down-regulated [36]; this leads to less contractile-
mediated glucose uptake and more circulating glucose 
in the bloodstream. Being at higher risk for diabetes 
may increase susceptibility to insulin resistance, thus 
impairing the action of insulin mediated glucose dis-
posal [37]. Therefore, those at higher risk for diabetes 
may have diminished capacity for homeostatic control 
of glucose when exposed to high volumes of sitting dur-
ing the day. Considering mean estimates only, those 
with higher risk did exhibit a propensity for greater 
levels of 2hPLG with compositions higher in sitting 
and lower in stepping, and greater relative attenuation 
of 2hPLG levels with compositions higher in stepping 
and lower in sitting when compared to the lower risk 
(Fig.  1D). However, the overlapping confidence inter-
vals suggest no significant difference by risk group for 
these relationships. Interestingly, compositions with 
higher stepping, and less sleeping were associated with 
reduced 2hPLG too. Evidence outlining favorable sleep 
duration supports 7 – 8 h per day, and sleep time that 
extends beyond this duration is associated with less 
beneficial health outcomes [11]. Given the mean sleep-
ing period for both risk groups was > 8.4 h per day, it is 
not unfeasible that excessive sleep durations, especially 
in place of daily physical activity, may be less favourable 
for glycaemic control. These findings however should be 
interpreted with caution given the cross-sectional study 
design, where reverse causation (i.e. worsened metabo-
lism provokes longer sleep durations) cannot be ruled 
out. Future studies incorporating larger sample sizes, 
and a longitudinal study design should investigate these 
findings further.
Compositions that had 60 min more stepping time and 
equivalent reduction in sitting time had comparable asso-
ciations with glucose outcomes to those that have previ-
ously been reported in a physical activity intervention. 
Gong et  al. [38] determined that physical interventions 
achieved significant 2hPLG reductions when compar-
ing the standardised mean differences to controls (SMD: 
−0.42; 95% CI: − 0.63, − 0.20). The results of the present 
study are comparable, albeit of lower magnitude, for both 
lower (SMD: −0.16 95%CI: −0.19, − 0.13) and higher 
risk (SMD: −0.13 95%CI: − 0.15, − 0.10) when compar-
ing more physically active compositions to the original 
geometric mean composition. Difference in magnitudes 
may be explained by physical activity interventions spe-
cifically involving participants in more intensive, and 
controlled experimental approaches as opposed to the 
free-living context of the present study.
Recent public health and clinical practice guidelines 
now emphasise the importance of not only reducing 
total sedentary time, but also increasing total physi-
cal activity through moving more throughout the day 
– ‘sit less and move more’ [3]. Our findings suggest that 
for glucose outcomes, this approach may be of greater 
importance in those at higher risk for development of 
diabetes, which is aligned with landmark diabetes pre-
vention trials primarily targeting those at elevated risk 
[39]. A recent systematic review by Hadgraft et  al. [40] 
evaluated a large sample of sedentary behaviour change 
interventions and determined only small benefit of 
reducing sedentary time on FPG. Given the findings of 
the present study, the small benefit to glucose levels may 
be explained by the majority of included studies recruit-
ing the general population (therefore not necessarily at 
high risk of chronic disease), as well as having a degree 
of heterogeneity between intervention components and 
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intervention messaging. Notably, most of the interven-
tion trials in the systematic review resulted in increased 
standing behaviours only, as opposed to changes to 
stepping levels. Future interventions should target the 
replacement of sedentary behaviour with both standing 
and stepping behaviours, and target those at elevated 
risk of diabetes.
The main strengths of this study were the measurement 
of 24 h posture time-use with device-based measures in 
the free-living context, as well the interpretation of this 
with a CoDA technique. The participants were recruited 
from the general Australian population, indicating that 
these findings may apply to a broader population, how-
ever it should be noted that this study’s subsample of par-
ticipants were on average healthier than the main sample 
[7]. By using the activPAL device it was possible to accu-
rately interpret postures such sitting, standing, and step-
ping, which has rarely been applied to a cohort at risk of 
diabetes. However, findings do need to be considered in 
the context of the limitations. Notably, cross-sectional 
analyses preclude causal inference. Another limitation 
is that selection bias may be present as stratification by 
diabetes risk group at 39 mmol/mol HbA1c may lead to 
reduced glucose outcome variability (and a greater chance 
of type 2 error); however there were similar estimates 
with 2hPLG between groups for sitting and stepping. The 
CoDA modeling did not account for patterns of time (e.g. 
short or long periods of sitting /or stepping), intensity 
(light, moderate, or vigorous intensity), nor sleep qual-
ity, which are known to have independent associations 
with cardiometabolic biomarkers [8, 41, 42]. There may 
have been some errors in the sleep estimate as sleep onset 
was self-reported or automatically estimated rather than 
objectively measured.
Conclusion
In conclusion, these findings from an examination of 24 h 
time-use (composed of sitting, standing, stepping and sleep-
ing) in participants going about their normal daily lives, sug-
gest that in middle-aged and older adults, glycaemic control 
could be improved by reducing daily sitting time and sup-
plementing it with standing or stepping, especially so in 
those at higher risk of developing type 2 diabetes.
Tables
See Tables 1, 2 and 3.
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